Lv4
412 积分 2025-03-29 加入
Corticosteroid administration for cancer-related indications is an unfavorable prognostic factor in solid cancer patients receiving immune checkpoint inhibitor treatment
27天前
已完结
Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)
1个月前
已完结
Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)
1个月前
已完结
PP01.11 Furmonertinib is an Oral, Irreversible, Highly Brain-Penetrant Pan-EGFR Inhibitor with Activity Against Classical and Atypical EGFR Mutations
2个月前
已完结
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study
2个月前
已完结
Cerebrospinal Fluid Metabolomics and Machine Learning Identify Novel Biomarkers for Lung Cancer Leptomeningeal Metastasis
2个月前
已完结
Can a High-Dose of Furmonertinib Effectively Address Unmet Needs in EGFR-Mutated NSCLC with Leptomeningeal Metastases?
2个月前
已完结
"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
2个月前
已完结
Leptomeningeal metastases in non-small-cell lung cancer
2个月前
已完结
Leptomeningeal metastases in non-small-cell lung cancer
2个月前
已完结
皖公网安备34019202002308
